CJC-1295 DAC
Synthetic GHRH analog with Drug Affinity Complex for extended half-life. Provides sustained GH elevation. Often combined with Ipamorelin.
Overview
Synthetic GHRH analog with Drug Affinity Complex for extended half-life. Provides sustained GH elevation. Often combined with Ipamorelin.
Elevates GH and IGF-1 levels (sustained release), may mildly elevate fasting glucose, can cause water retention and numbness/tingling, less cortisol/prolactin impact than GHRP-6. Generally well tolerated on blood markers.
Compound Guide
Structure: Modified GRF(1-29) with a Drug Affinity Complex that binds to albumin, dramatically extending half-life from minutes to days.
Dosage:
- Standard: 2mg/week (single injection)
- Enhanced: 2mg 2x/week
- Combined with Ipamorelin: 2mg CJC-1295 DAC/week + Ipamorelin 200-300mcg 2-3x/day
Administration:
- SubQ injection, once or twice weekly due to long half-life
- Abdomen, rotate injection sites
- Take on empty stomach for optimal GH release
Key Notes:
- The DAC (Drug Affinity Complex) extends the half-life dramatically — provides continuous GH elevation rather than pulsatile release
- Creates a sustained "GH bleed" — elevated baseline GH throughout the week
- This continuous elevation is less physiological than pulsatile GH release (Tesamorelin, mod-GRF/Ipamorelin)
- Water retention and numbness/tingling in extremities are common (signs of elevated GH)
- Monitor: IGF-1, fasting glucose, HbA1c
- Some users prefer mod-GRF (CJC-1295 without DAC) for more natural pulsatile release
- Synergistic with GHRP peptides (Ipamorelin, GHRP-2, GHRP-6)
Which labs to run on a GHRH plus secretagogue stack, and what good looks like: How to read your labs on CJC-1295 and ipamorelin.
Usage History
Pairs With
How CJC-1295 DAC behaves when it is run alongside other compounds.
Commonly stacked with
Stacks the risk
Frequently Asked Questions
Related Articles
How Tesamorelin Cuts Visceral Fat Without Raising Blood Sugar
Tesamorelin cuts visceral fat 15-18% in 26 weeks while keeping glucose neutral. Bloodwork protocol, decision tree, and how it compares to CJC and MK-677.
Blood Tests Every SARMs and Peptide User Should Run in 2026
MK-677 wrecks glucose. RAD-140 tanks HDL. The exact bloodwork to run before, during, and after SARMs or peptides, with compound-specific thresholds that should stop your cycle.
Quick Reference
Category
Peptide
Half-Life
6-8 days (with DAC)
Detection Time
N/A